Dendritic cell fate is determined by BCL11A

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages

  Ippolito, Gregory C ^a   Dekker, Joseph D ^a   Wang, Yui Hsi ^b   Lee, Bum Kyu ^a   Shaffer III, Arthur L ^c   Lin, Jian ^a   Wall, Jason K ^a   Lee, Baeck Seung ^a   Staudt, Louis M ^c   Liu, Yong Jun ^d   Iyer, Vishwanath R ^a   Tucker, Haley O ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL11A PROTEIN; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; BONE MARROW CULTURE; CELL FATE; CELL LINEAGE; CELL POPULATION; CONTROLLED STUDY; DNA BINDING; DNA BINDING MOTIF; EMBRYO; FETUS; FETUS LIVER; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GERM LINE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TRANSIENT TRANSFECTION; YOUNG ADULT;

ANIMALS; B-LYMPHOCYTES; CARRIER PROTEINS; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84896532122     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1319228111     Document Type: Article

References (58)

1. Fell HP, Smith RG, Tucker PW (1986) Molecular analysis of the t(2;14) translocation of childhood chronic lymphocytic leukemia. Science 232(4749):491-494. (Pubitemid 16052360)
2. Satterwhite E, et al. (2001) The BCL11 gene family: Involvement of BCL11A in lymphoid malignancies. Blood 98(12):3413-3420.
3. Mitelman F, Johansson B, Mertens F (2004) Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nat Genet 36(4):331-334. (Pubitemid 38437252)
4. Liu H, et al. (2006) Functional studies of BCL11A: Characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Mol Cancer 5:18.
5. Liu P, et al. (2003) Bcl11a is essential for normal lymphoid development. Nat Immunol 4(6):525-532. (Pubitemid 36701334)
6. Yu Y, et al. (2012) Bcl11a is essential for lymphoid development and negatively regulates p53. J Exp Med 209(13):2467-2483.
7. Kustikova O, et al. (2005) Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308(5725):1171-1174. (Pubitemid 40696434)
8. Pelayo R, et al. (2005) Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow. Blood 105(11):4407-4415. (Pubitemid 40720788)
9. Wu X, et al. (2013) Bcl11a controls Flt3 expression in early hematopoietic progenitors and is required for pDC development in vivo. PLoS ONE 8(5):e64800.
10. Wu L, Liu YJ (2007) Development of dendritic-cell lineages. Immunity 26(6):741-750. (Pubitemid 46908964)
11. Reizis B (2010) Regulation of plasmacytoid dendritic cell development. Curr Opin Immunol 22(2):206-211.
12. Swiecki M, Colonna M (2010) Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 234(1):142-162.
13. Robbins SH, et al. (2008) Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol 9(1):R17.
14. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5(12):1219-1226. (Pubitemid 41057736)
15. Shigematsu H, et al. (2004) Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 21(1):43-53. (Pubitemid 38925266)
16. Wang YH, Liu YJ (2004) Mysterious origin of plasmacytoid dendritic cell precursors. Immunity 21(1):1-2.
17. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V (2011) Plasmacytoid dendritic cells: Recent progress and open questions. Annu Rev Immunol 29:163-183.
18. Cisse B, et al. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135(1):37-48.
19. Ghosh HS, Cisse B, Bunin A, Lewis KL, Reizis B (2010) Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 33(6):905-916.
20. Miller JC, et al.; Immunological Genome Consortium (2012) Deciphering the transcriptional network of the dendritic cell lineage. Nat Immunol 13(9):888-899.
21. Kee BL (2009) E and ID proteins branch out. Nat Rev Immunol 9(3):175-184.
22. Lin YC, et al. (2010) A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 11(7):635-643.
23. Deed RW, Jasiok M, Norton JD (1998) Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of E2A basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells. J Biol Chem 273(14): 8278-8286. (Pubitemid 28168885)
24. Hacker C, et al. (2003) Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 4(4):380-386. (Pubitemid 36432322)
25. Jaleco AC, et al. (1999) Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3. Blood 94(8):2637-2646. (Pubitemid 29477292)
26. Ji M, et al. (2008) Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins. Blood 112(4):1068-1077.
27. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH (2000) Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med 192(12):1775-1784.
28. Nagasawa M, Schmidlin H, Hazekamp MG, Schotte R, Blom B (2008) Development of human plasmacytoid dendritic cells depends on the combined action of the basic helix-loop-helix factor E2-2 and the Ets factor Spi-B. Eur J Immunol 38(9):2389-2400.
29. Miyazaki M, et al. (2011) The opposing roles of the transcription factor E2A and its antagonist Id3 that orchestrate and enforce the naive fate of T cells. Nat Immunol 12(10):992-1001.
30. Jones-Mason ME, et al. (2012) E protein transcription factors are required for the development of CD4(+) lineage T cells. Immunity 36(3):348-361.
31. Loveys DA, Streiff MB, Kato GJ (1996) E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein. Nucleic Acids Res 24(14):2813-2820. (Pubitemid 26239754)
32. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD (2001) Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol Cell Biol 21(2):524-533. (Pubitemid 32037372)
33. Gilliet M, et al. (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony- stimulating factor. J Exp Med 195(7):953-958. (Pubitemid 34286765)
34. Esashi E, et al. (2008) The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28(4):509-520.
35. Sankaran VG, et al. (2009) Developmental and species-divergent globin switching are driven by BCL11A. Nature 460(7259):1093-1097.
36. Xu J, et al. (2010) Transcriptional silencing of gamma-globin by BCL11A involves longrange interactions and cooperation with SOX6. Genes Dev 24(8):783-798.
37. Kühn R, Schwenk F, Aguet M, Rajewsky K (1995) Inducible gene targeting in mice. Science 269(5229):1427-1429.
38. Georgiades P, et al. (2002) VavCre transgenic mice: A tool for mutagenesis in hematopoietic and endothelial lineages. Genesis 34(4):251-256. (Pubitemid 35470699)
39. Stadtfeld M, Graf T (2005) Assessing the role of hematopoietic plasticity for endothelial and hepatocyte development by non-invasive lineage tracing. Development 132(1):203-213. (Pubitemid 40207979)
40. Felker P, et al. (2010) TGF-beta1 accelerates dendritic cell differentiation from common dendritic cell progenitors and directs subset specification toward conventional dendritic cells. J Immunol 185(9):5326-5335.
41. Ghosh HS, Liu K, Hiebert S, Reizis B (2012) Eto2/MTG16 regulates E-protein activity and subset specification in dendritic cell development. Blood 120(21). Available at https://ash.confex.com/ash/2012/webprogram/Paper53299. html.
42. Su AI, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101(16):6062-6067. (Pubitemid 38520528)
43. Shaffer AL, et al. (2006) A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev 210:67-85.
44. Pulford K, et al. (2006) The BCL11AXL transcription factor: Its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. Leukemia 20(8):1439-1441. (Pubitemid 44084060)
45. Satpathy AT, Murphy KM, Kc W (2011) Transcription factor networks in dendritic cell development. Semin Immunol 23(5):388-397.
46. Laurenti E, et al. (2013) The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat Immunol 14(7):756-763.
47. Blom B, Ho S, Antonenko S, Liu YJ (2000) Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 192(12):1785-1796.
48. Ishikawa F, et al. (2007) The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood 110(10):3591-3660.
49. Boos MD, Yokota Y, Eberl G, Kee BL (2007) Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 204(5):1119-1130. (Pubitemid 46798155)
50. Li P, et al. (2010) Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329(5987):85-89.
51. Carotta S, Wu L, Nutt SL (2010) Surprising new roles for PU.1 in the adaptive immune response. Immunol Rev 238(1):63-75.
52. Glasmacher E, et al. (2012) A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338(6109):975-980.
53. Escalante CR, et al. (2002) Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell 10(5):1097-1105. (Pubitemid 35453827)
54. Tamura T, et al. (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol 174(5):2573-2581. (Pubitemid 40279670)
55. Lee BS, et al. (2013) The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombination. Mol Cell Biol 33(9):1768-1781.
56. Alizadeh A, et al. (1999) The LymphoChip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harb Symp Quant Biol 64:71-78. (Pubitemid 30329266)
57. Lee BK, Bhinge AA, Iyer VR (2011) Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis. Nucleic Acids Res 39(9): 3558-3573.
58. Ngo VN, et al. (2006) A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441(7089):106-110.